Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation.
Khan RS, Kato TS, Chokshi A, Chew M, Yu S, Wu C, Singh P, Cheema FH, Takayama H, Harris C, Reyes-Soffer G, Knöll R, Milting H, Naka Y, Mancini D, Schulze PC. Khan RS, et al. Among authors: kato ts. Circ Heart Fail. 2012 May 1;5(3):340-8. doi: 10.1161/CIRCHEARTFAILURE.111.964031. Epub 2012 Feb 29. Circ Heart Fail. 2012. PMID: 22379072 Free PMC article.
Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure.
Chokshi A, Drosatos K, Cheema FH, Ji R, Khawaja T, Yu S, Kato T, Khan R, Takayama H, Knöll R, Milting H, Chung CS, Jorde U, Naka Y, Mancini DM, Goldberg IJ, Schulze PC. Chokshi A, et al. Circulation. 2012 Jun 12;125(23):2844-53. doi: 10.1161/CIRCULATIONAHA.111.060889. Epub 2012 May 14. Circulation. 2012. PMID: 22586279 Free PMC article.
Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure.
Kato TS, Chokshi A, Singh P, Khawaja T, Iwata S, Homma S, Akashi H, Cheema F, Yang J, Takayama H, Naka Y, Farr M, Mancini D, Schulze PC. Kato TS, et al. J Heart Lung Transplant. 2012 Jan;31(1):37-45. doi: 10.1016/j.healun.2011.10.007. Epub 2011 Nov 9. J Heart Lung Transplant. 2012. PMID: 22071239
Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.
Yang JA, Kato TS, Shulman BP, Takayama H, Farr M, Jorde UP, Mancini DM, Naka Y, Schulze PC. Yang JA, et al. Among authors: kato ts. J Heart Lung Transplant. 2012 Jun;31(6):601-10. doi: 10.1016/j.healun.2012.02.027. Epub 2012 Mar 28. J Heart Lung Transplant. 2012. PMID: 22458997 Free PMC article.
Increased levels of retinol binding protein 4 in patients with advanced heart failure correct after hemodynamic improvement through ventricular assist device placement.
Chavarria N, Kato TS, Khan R, Chokshi A, Collado E, Akashi H, Takayama H, Naka Y, Farr M, Mancini D, Schulze PC. Chavarria N, et al. Among authors: kato ts. Circ J. 2012;76(9):2148-52. doi: 10.1253/circj.cj-12-0350. Epub 2012 Jun 12. Circ J. 2012. PMID: 22785609 Free article. Clinical Trial.
99 results